Claudin 18.2-directed Cytolytic Antibody [EPC]

Claudin 18.2-directed Cytolytic Antibody [EPC] was reported 1525 times

Drugs of the Claudin 18.2-directed Cytolytic Antibody [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ADENOCARCINOMA GASTRIC RECURRENT 2 0.6667
1 METASTASES TO PERINEUM 3 0.2727
2 OESOPHAGOGASTROSCOPY ABNORMAL 1 0.1667
3 INSTILLATION SITE HYPOAESTHESIA 1 0.1429
4 RED CELL DISTRIBUTION WIDTH 1 0.1000
5 PROTEIN-LOSING GASTROENTEROPATHY 25 0.0503
6 PORTAL VEIN EMBOLISM 1 0.0385
7 PREPYLORIC STENOSIS 1 0.0370
8 CYTOTOXIC LESIONS OF CORPUS CALLOSUM 5 0.0338
9 GASTRITIS HYPERTROPHIC 1 0.0244
10 THROMBOPHLEBITIS MIGRANS 8 0.0235
11 TUMOUR OBSTRUCTION 2 0.0230
12 IGM NEPHROPATHY 1 0.0213
13 PERITUMOURAL OEDEMA 1 0.0208
14 CATHETER SITE PHLEBITIS 1 0.0192
15 HYPOZINCAEMIA 1 0.0169
16 LOWER GASTROINTESTINAL PERFORATION 1 0.0169
17 HYPOALBUMINAEMIA 129 0.0166
18 GASTRIC STENOSIS 3 0.0164
19 METASTASES TO DIAPHRAGM 1 0.0147
20 BLOOD ALBUMIN DECREASED 100 0.0126
21 GASTRIC MUCOSA ERYTHEMA 4 0.0121
22 AMOEBIC COLITIS 1 0.0110
23 METASTASES TO OESOPHAGUS 1 0.0106
24 MALIGNANT ASCITES 8 0.0104
25 ACUTE CHOLECYSTITIS NECROTIC 2 0.0100
26 FLUID INTAKE RESTRICTION 1 0.0091
27 KL-6 INCREASED 2 0.0088
28 GASTROINTESTINAL STENOSIS 4 0.0088
29 SPLENIC EMBOLISM 1 0.0087
30 INTESTINAL METASTASIS 3 0.0083
31 PNEUMOCOCCAL BACTERAEMIA 1 0.0079
32 GASTRIC CANCER RECURRENT 1 0.0077
33 CARBOHYDRATE ANTIGEN 19-9 INCREASED 4 0.0076
34 GASTROINTESTINAL MUCOSAL EXFOLIATION 1 0.0075
35 MESENTERIC ARTERIAL OCCLUSION 1 0.0071
36 PNEUMONIA CHLAMYDIAL 1 0.0064
37 RECTAL STENOSIS 2 0.0060
38 PYLORIC STENOSIS 5 0.0059
39 NUTRITIONAL CONDITION ABNORMAL 4 0.0057
40 PERICARDIAL EFFUSION MALIGNANT 1 0.0056
41 METASTASES TO PERITONEUM 14 0.0055
42 METASTASES TO MUSCLE 1 0.0055
43 BLOOD ZINC DECREASED 1 0.0055
44 VASCULAR PAIN 5 0.0052
45 TUMOUR EMBOLISM 1 0.0052
46 GASTROINTESTINAL OEDEMA 9 0.0051
47 ADULT FAILURE TO THRIVE 1 0.0047
48 IMMOBILISATION SYNDROME 1 0.0047
49 ASCITES 138 0.0047
50 PHYSICAL DECONDITIONING 12 0.0047
51 HYPOPROTEINAEMIA 8 0.0042
52 JEJUNAL PERFORATION 1 0.0041
53 GASTRIC MUCOSAL LESION 3 0.0041
54 SPONTANEOUS BACTERIAL PERITONITIS 1 0.0041
55 GASTRIC MUCOSAL HYPERTROPHY 1 0.0040
56 URTICARIA PAPULAR 1 0.0039
57 METASTASES TO SOFT TISSUE 1 0.0039
58 PROCEDURAL INTESTINAL PERFORATION 1 0.0037
59 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 1 0.0037
60 BLOOD CHOLINESTERASE DECREASED 1 0.0036
61 ENTEROCOLITIS BACTERIAL 1 0.0036
62 CARCINOEMBRYONIC ANTIGEN INCREASED 7 0.0036
63 GALLBLADDER OEDEMA 1 0.0034
64 CATHETER SITE CELLULITIS 1 0.0034
65 DUODENAL OBSTRUCTION 1 0.0033
66 VENOUS HAEMORRHAGE 1 0.0032
67 HEPATECTOMY 1 0.0032
68 BENIGN OVARIAN TUMOUR 1 0.0031
69 METASTASES TO OVARY 1 0.0031
70 GASTROINTESTINAL MUCOSAL DISORDER 2 0.0031
71 METASTASES TO BREAST 1 0.0030
72 VASCULAR DEVICE OCCLUSION 1 0.0029
73 STASIS DERMATITIS 2 0.0029
74 PROTEIN TOTAL DECREASED 11 0.0029
75 ANION GAP DECREASED 1 0.0029
76 TRACHEAL HAEMORRHAGE 1 0.0028
77 ANASTOMOTIC STENOSIS 1 0.0027
78 MEDIASTINAL DISORDER 1 0.0027
79 THROMBOTIC CEREBRAL INFARCTION 1 0.0027
80 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 1 0.0026
81 MESENTERIC ARTERY THROMBOSIS 1 0.0026
82 BILE DUCT STENOSIS 3 0.0025
83 BILIARY OBSTRUCTION 3 0.0023
84 TISSUE INJURY 1 0.0023
85 PNEUMATOSIS 1 0.0022
86 HEPATIC ATROPHY 1 0.0022
87 SALIVARY HYPERSECRETION 22 0.0022
88 METASTASES TO MENINGES 5 0.0022
89 TRAUMATIC INTRACRANIAL HAEMORRHAGE 2 0.0022
90 CARDIAC TAMPONADE 10 0.0021
91 BLOOD CREATINE ABNORMAL 1 0.0021
92 ONCOLOGIC COMPLICATION 2 0.0021
93 GENITAL ERYTHEMA 1 0.0020
94 HICCUPS 16 0.0019
95 URETEROLITHIASIS 2 0.0019
96 RECTAL PERFORATION 1 0.0019
97 HYPERAMYLASAEMIA 1 0.0018
98 MYELOSUPPRESSION 66 0.0018
99 TUMOUR PSEUDOPROGRESSION 2 0.0018
100 MALIGNANT PLEURAL EFFUSION 3 0.0018
101 OESOPHAGEAL STENOSIS 5 0.0018
102 MECHANICAL ILEUS 1 0.0018
103 GASTRITIS 46 0.0017
104 HYPERAMMONAEMIC ENCEPHALOPATHY 3 0.0017
105 RETROPERITONEAL FIBROSIS 1 0.0017
106 MALIGNANT PERITONEAL NEOPLASM 1 0.0017
107 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
108 PSOAS ABSCESS 1 0.0016
109 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 2 0.0016
110 RECTAL FISSURE 1 0.0016
111 BACILLUS INFECTION 1 0.0016
112 MALLORY-WEISS SYNDROME 2 0.0016
113 GASTROINTESTINAL EROSION 1 0.0016
114 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
115 OBSTRUCTION GASTRIC 2 0.0016
116 NEUTROPHIL COUNT DECREASED 63 0.0015
117 EMBOLIC CEREBRAL INFARCTION 1 0.0015
118 SPUTUM ABNORMAL 1 0.0015
119 PERFORMANCE STATUS DECREASED 7 0.0015
120 URETERIC OBSTRUCTION 2 0.0015
121 ATRIAL THROMBOSIS 3 0.0014
122 ANASTOMOTIC LEAK 1 0.0014
123 FANCONI SYNDROME 2 0.0014
124 PULMONARY TOXICITY 10 0.0014
125 BLOOD ELECTROLYTES DECREASED 2 0.0014
126 SCROTAL OEDEMA 1 0.0014
127 HYPERAMMONAEMIA 7 0.0014
128 ENTEROCOLITIS 8 0.0014
129 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
130 DYSLALIA 1 0.0014
131 GASTROINTESTINAL SCARRING 1 0.0014
132 TUMOUR LYSIS SYNDROME 12 0.0014
133 GASTRITIS HAEMORRHAGIC 2 0.0013
134 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
135 PULMONARY ARTERY THROMBOSIS 1 0.0013
136 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
137 ILEUS 16 0.0013
138 DIARRHOEA INFECTIOUS 1 0.0013
139 LACUNAR INFARCTION 3 0.0013
140 URETERIC STENOSIS 1 0.0012
141 METABOLIC ALKALOSIS 2 0.0012
142 GASTROINTESTINAL OBSTRUCTION 3 0.0012
143 EXCESSIVE GRANULATION TISSUE 1 0.0012
144 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
145 ENTERITIS INFECTIOUS 2 0.0012
146 ATONIC SEIZURES 1 0.0012
147 MALIGNANT NEOPLASM PROGRESSION 117 0.0011
148 FANCONI SYNDROME ACQUIRED 2 0.0011
149 SALIVA ALTERED 1 0.0011
150 GASTRIC PERFORATION 3 0.0011
151 MUCOSAL EROSION 1 0.0011
152 FEEDING DISORDER 22 0.0011
153 BLOOD CHOLESTEROL DECREASED 2 0.0011
154 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
155 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
156 INTUSSUSCEPTION 1 0.0010
157 TUMOUR MARKER INCREASED 5 0.0010
158 VOMITING PROJECTILE 3 0.0010
159 METASTASES TO LYMPH NODES 7 0.0010
160 ARTERIAL THROMBOSIS 2 0.0010
161 PERIPHERAL SENSORY NEUROPATHY 6 0.0010
162 DUODENAL PERFORATION 1 0.0010
163 DEVICE RELATED THROMBOSIS 1 0.0010
164 SPUTUM RETENTION 1 0.0010
165 PRINZMETAL ANGINA 1 0.0010
166 DYSAESTHESIA 3 0.0010
167 OEDEMA 53 0.0010
168 FULMINANT TYPE 1 DIABETES MELLITUS 1 0.0010
169 GENERALISED OEDEMA 12 0.0010
170 CAPILLARY LEAK SYNDROME 2 0.0010
171 METASTASES TO PLEURA 1 0.0010
172 OEDEMA MUCOSAL 1 0.0010
173 TUMOUR NECROSIS 1 0.0009
174 HYDROCELE 1 0.0009
175 PORTAL VEIN THROMBOSIS 3 0.0009
176 PRODUCT PREPARATION ISSUE 6 0.0009
177 CEREBRAL INFARCTION 22 0.0009
178 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
179 MOTOR DYSFUNCTION 9 0.0009
180 PNEUMONIA ASPIRATION 22 0.0009
181 PO2 DECREASED 1 0.0009
182 AORTIC THROMBOSIS 1 0.0009
183 DECREASED APPETITE 201 0.0009
184 PAROTITIS 1 0.0009
185 EPIDIDYMITIS 1 0.0009
186 JAUNDICE CHOLESTATIC 3 0.0008
187 EMBOLISM ARTERIAL 1 0.0008
188 CEREBRAL ARTERY EMBOLISM 1 0.0008
189 HAEMATOLOGICAL INFECTION 2 0.0008
190 LARGE INTESTINE INFECTION 1 0.0008
191 BLOOD UREA DECREASED 1 0.0008
192 HYDRONEPHROSIS 6 0.0008
193 MEAN CELL VOLUME INCREASED 2 0.0008
194 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
195 DACRYOSTENOSIS ACQUIRED 1 0.0008
196 FAILURE TO THRIVE 4 0.0008
197 PNEUMONIA BACTERIAL 7 0.0008
198 HYPOVITAMINOSIS 1 0.0008
199 INTESTINAL DILATATION 1 0.0007
200 COMPRESSION FRACTURE 4 0.0007
201 CARBON DIOXIDE INCREASED 1 0.0007
202 EFFUSION 1 0.0007
203 ISCHAEMIC HEPATITIS 1 0.0007
204 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17 0.0007
205 INFUSION SITE RASH 1 0.0007
206 INTESTINAL ISCHAEMIA 4 0.0007
207 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
208 GASTROINTESTINAL PERFORATION 3 0.0007
209 LARGE INTESTINE PERFORATION 5 0.0007
210 PRERENAL FAILURE 1 0.0007
211 HYPERPYREXIA 3 0.0007
212 NAUSEA 558 0.0007
213 RETCHING 15 0.0007
214 TUMOUR HAEMORRHAGE 2 0.0007
215 INJECTION SITE HYPOAESTHESIA 1 0.0007
216 RENAL INFARCT 1 0.0007
217 ONYCHOMYCOSIS 3 0.0007
218 ANGIOPLASTY 1 0.0007
219 VASCULAR DEVICE INFECTION 3 0.0007
220 INFECTIOUS PLEURAL EFFUSION 1 0.0007
221 PNEUMONIA PSEUDOMONAL 1 0.0007
222 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
223 FULL BLOOD COUNT DECREASED 13 0.0006
224 GASTRITIS EROSIVE 3 0.0006
225 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
226 TASTE DISORDER 13 0.0006
227 FUNGAEMIA 1 0.0006
228 VENOOCCLUSIVE LIVER DISEASE 3 0.0006
229 EMBOLISM 5 0.0006
230 GASTRIC DILATATION 1 0.0006
231 INTERSTITIAL LUNG DISEASE 29 0.0006
232 CEREBELLAR INFARCTION 1 0.0006
233 CARBOHYDRATE ANTIGEN 125 INCREASED 2 0.0006
234 REGURGITATION 2 0.0006
235 VOMITING 271 0.0006
236 TYPE I HYPERSENSITIVITY 2 0.0006
237 HYPOKALAEMIA 26 0.0006
238 OEDEMA PERIPHERAL 67 0.0005
239 HEPATIC CYTOLYSIS 7 0.0005
240 METASTASES TO BONE 9 0.0005
241 HYPOPHAGIA 14 0.0005
242 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
243 HYPOPHOSPHATAEMIA 4 0.0005
244 MALNUTRITION 6 0.0005
245 HEPATIC ENCEPHALOPATHY 5 0.0005
246 SMALL INTESTINAL PERFORATION 1 0.0005
247 INTERVERTEBRAL DISCITIS 1 0.0005
248 TRAUMATIC LUNG INJURY 1 0.0005
249 EARLY SATIETY 1 0.0005
250 HYPOVOLAEMIA 3 0.0005
251 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
252 OESOPHAGEAL CANDIDIASIS 2 0.0005
253 AZOTAEMIA 2 0.0005
254 LARGE INTESTINAL STENOSIS 1 0.0005
255 ANAPHYLACTOID REACTION 2 0.0005
256 CHOLANGITIS 3 0.0005
257 INFUSION RELATED REACTION 32 0.0005
258 MICROCYTIC ANAEMIA 1 0.0005
259 LUNG ABSCESS 1 0.0005
260 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
261 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
262 HYPERPHOSPHATAEMIA 1 0.0005
263 METASTATIC NEOPLASM 2 0.0005
264 PYELONEPHRITIS 4 0.0005
265 PLEURAL EFFUSION 28 0.0005
266 CARDIAC FAILURE ACUTE 3 0.0004
267 PARESIS 1 0.0004
268 LARGE INTESTINAL OBSTRUCTION 1 0.0004
269 CHRONIC GASTRITIS 1 0.0004
270 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
271 ELECTROLYTE IMBALANCE 5 0.0004
272 PULMONARY INFARCTION 1 0.0004
273 NEUROPATHY PERIPHERAL 40 0.0004
274 KIDNEY TRANSPLANT REJECTION 2 0.0004
275 GASTROINTESTINAL TOXICITY 2 0.0004
276 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
277 HYPERNATRAEMIA 2 0.0004
278 CATHETER SITE HAEMORRHAGE 1 0.0004
279 SECRETION DISCHARGE 5 0.0004
280 TOXIC ENCEPHALOPATHY 2 0.0004
281 DERMATOMYOSITIS 1 0.0004
282 TROPONIN INCREASED 3 0.0004
283 PLATELET COUNT DECREASED 42 0.0004
284 AMMONIA INCREASED 2 0.0004
285 INCREASED BRONCHIAL SECRETION 1 0.0004
286 ENDOCARDITIS 2 0.0004
287 CACHEXIA 2 0.0004
288 BLOOD CHLORIDE DECREASED 1 0.0004
289 LUNG OPACITY 1 0.0004
290 PNEUMOTHORAX 6 0.0004
291 HEPATIC FUNCTION ABNORMAL 14 0.0004
292 BLOOD SODIUM INCREASED 1 0.0004
293 RENAL IMPAIRMENT 31 0.0004
294 DECUBITUS ULCER 3 0.0004
295 DEHYDRATION 49 0.0004
296 ORAL FUNGAL INFECTION 1 0.0004
297 FEBRILE NEUTROPENIA 24 0.0004
298 PROCTITIS 1 0.0004
299 SKIN HYPERTROPHY 1 0.0004
300 NEUTROPHIL COUNT ABNORMAL 1 0.0004
301 PRODUCT ADMINISTRATION ERROR 7 0.0003
302 DELIRIUM 12 0.0003
303 STRESS CARDIOMYOPATHY 2 0.0003
304 BILIARY COLIC 1 0.0003
305 BACTERAEMIA 4 0.0003
306 OROPHARYNGEAL DISCOMFORT 3 0.0003
307 VARICES OESOPHAGEAL 1 0.0003
308 EMBOLISM VENOUS 1 0.0003
309 ADRENAL INSUFFICIENCY 4 0.0003
310 FIBROSIS 1 0.0003
311 INTERCEPTED PRODUCT PREPARATION ERROR 4 0.0003
312 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
313 HEPATIC CIRRHOSIS 6 0.0003
314 BLOOD CREATININE DECREASED 1 0.0003
315 POLYMYALGIA RHEUMATICA 1 0.0003
316 BILE DUCT STONE 1 0.0003
317 THROMBOSIS IN DEVICE 1 0.0003
318 HYPOGAMMAGLOBULINAEMIA 2 0.0003
319 LISTLESS 1 0.0003
320 METASTASES TO SPINE 1 0.0003
321 COLITIS ISCHAEMIC 2 0.0003
322 BLOOD BILIRUBIN INCREASED 8 0.0003
323 WOUND COMPLICATION 1 0.0003
324 METASTASES TO LIVER 5 0.0003
325 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
326 EMBOLIC STROKE 1 0.0003
327 FIBRIN D DIMER INCREASED 1 0.0003
328 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
329 SUBDURAL HAEMATOMA 4 0.0003
330 GASTRIC CANCER 7 0.0003
331 MONOCYTE COUNT INCREASED 1 0.0003
332 SPONDYLITIS 1 0.0003
333 CUTANEOUS VASCULITIS 1 0.0003
334 ASPIRATION 3 0.0003
335 ANAPHYLACTIC SHOCK 7 0.0003
336 HYPERTENSIVE CRISIS 3 0.0003
337 BLOOD CALCIUM DECREASED 3 0.0003
338 CATHETER SITE INFECTION 1 0.0003
339 COLITIS 10 0.0003
340 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
341 PROCEDURAL HAEMORRHAGE 1 0.0003
342 VENOUS THROMBOSIS 1 0.0003
343 NAIL DISCOLOURATION 1 0.0003
344 PNEUMONIA FUNGAL 1 0.0003
345 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
346 ORGAN FAILURE 1 0.0002
347 STOMATITIS 15 0.0002
348 ASPHYXIA 2 0.0002
349 HYPERURICAEMIA 1 0.0002
350 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
351 HYPOAESTHESIA 36 0.0002
352 INTESTINAL STENOSIS 1 0.0002
353 HEPATIC PAIN 1 0.0002
354 PULMONARY TUBERCULOSIS 1 0.0002
355 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
356 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
357 SEPTIC SHOCK 10 0.0002
358 COLD SWEAT 4 0.0002
359 PHYSICAL DISABILITY 1 0.0002
360 ILEUS PARALYTIC 1 0.0002
361 IRON DEFICIENCY 1 0.0002
362 SUSPECTED OFF LABEL USE 1 0.0002
363 NEUTROPENIA 30 0.0002
364 ABDOMINAL PAIN 51 0.0002
365 PERIPHERAL COLDNESS 3 0.0002
366 ISCHAEMIA 1 0.0002
367 RENAL FUNCTION TEST ABNORMAL 1 0.0002
368 APPENDICITIS 2 0.0002
369 INTESTINAL OBSTRUCTION 8 0.0002
370 HYPOCALCAEMIA 4 0.0002
371 GASTRIC ULCER 4 0.0002
372 URINARY RETENTION 7 0.0002
373 PULMONARY FIBROSIS 4 0.0002
374 RASH VESICULAR 1 0.0002
375 GUILLAIN-BARRE SYNDROME 1 0.0002
376 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
377 THROMBOTIC MICROANGIOPATHY 2 0.0002
378 RENAL CELL CARCINOMA 1 0.0002
379 ENCEPHALOPATHY 5 0.0002
380 ABDOMINAL TENDERNESS 1 0.0002
381 FLUID INTAKE REDUCED 1 0.0002
382 DERMATITIS EXFOLIATIVE 1 0.0002
383 PHLEBITIS 1 0.0002
384 NEUTROPHIL COUNT INCREASED 2 0.0002
385 DEVICE RELATED INFECTION 3 0.0002
386 INCREASED UPPER AIRWAY SECRETION 1 0.0002
387 WHITE BLOOD CELL COUNT DECREASED 21 0.0002
388 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
389 C-REACTIVE PROTEIN INCREASED 7 0.0002
390 MALABSORPTION 1 0.0002
391 BLOOD LACTIC ACID INCREASED 1 0.0002
392 POLYARTHRITIS 1 0.0002
393 PULMONARY EMBOLISM 18 0.0002
394 INCONTINENCE 2 0.0002
395 ANAL ABSCESS 1 0.0002
396 CHEILITIS 1 0.0002
397 DEEP VEIN THROMBOSIS 12 0.0002
398 MELAENA 4 0.0002
399 CHOKING SENSATION 1 0.0002
400 INTRACRANIAL PRESSURE INCREASED 1 0.0002
401 MACULAR OEDEMA 1 0.0002
402 NEPHROPATHY TOXIC 2 0.0002
403 FACE OEDEMA 3 0.0002
404 CHOLECYSTITIS ACUTE 1 0.0002
405 PRODUCT USE ISSUE 33 0.0002
406 ABDOMINAL PAIN UPPER 36 0.0002
407 SHOCK 4 0.0002
408 METABOLIC DISORDER 1 0.0002
409 NEUROTOXICITY 3 0.0002
410 HYPERKALAEMIA 6 0.0002
411 LYMPHOCYTE COUNT DECREASED 3 0.0002
412 WEIGHT DECREASED 47 0.0002
413 CHOLECYSTITIS 2 0.0002
414 POLYNEUROPATHY 2 0.0002
415 UNDERDOSE 12 0.0002
416 DERMATITIS ACNEIFORM 1 0.0002
417 SMALL INTESTINAL OBSTRUCTION 2 0.0002
418 PIGMENTATION DISORDER 1 0.0002
419 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
420 DISEASE PROGRESSION 19 0.0002
421 OXYGEN SATURATION DECREASED 9 0.0002
422 HYPONATRAEMIA 9 0.0002
423 SWELLING OF EYELID 1 0.0002
424 ANGIOEDEMA 7 0.0002
425 HAEMATEMESIS 4 0.0002
426 ENTERITIS 1 0.0002
427 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 28 0.0002
428 LACTIC ACIDOSIS 5 0.0002
429 BEDRIDDEN 2 0.0002
430 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
431 QUALITY OF LIFE DECREASED 2 0.0001
432 THROAT TIGHTNESS 4 0.0001
433 ANAEMIA 28 0.0001
434 IMPAIRED GASTRIC EMPTYING 2 0.0001
435 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
436 CHEST DISCOMFORT 15 0.0001
437 DROOLING 1 0.0001
438 FEELING COLD 4 0.0001
439 HYPOMAGNESAEMIA 2 0.0001
440 MALAISE 62 0.0001
441 HAND FRACTURE 1 0.0001
442 EATING DISORDER 3 0.0001
443 RETINAL HAEMORRHAGE 1 0.0001
444 LIVER FUNCTION TEST INCREASED 3 0.0001
445 VISUAL FIELD DEFECT 1 0.0001
446 APATHY 2 0.0001
447 CARDIAC FAILURE 11 0.0001
448 DYSPHAGIA 13 0.0001
449 CHILLS 16 0.0001
450 HYPOAESTHESIA ORAL 2 0.0001
451 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
452 EPILEPSY 4 0.0001
453 BLOOD PRESSURE INCREASED 20 0.0001
454 ACUTE KIDNEY INJURY 20 0.0001
455 PYREXIA 45 0.0001
456 THYROID DISORDER 2 0.0001
457 DIARRHOEA 82 0.0001
458 PANCYTOPENIA 7 0.0001
459 RHINITIS 1 0.0001
460 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
461 HEMIPLEGIA 1 0.0001
462 ABDOMINAL PAIN LOWER 3 0.0001
463 FLUSHING 12 0.0001
464 FACIAL PARALYSIS 1 0.0001
465 PSEUDOMONAS INFECTION 1 0.0001
466 BLOOD MAGNESIUM DECREASED 1 0.0001
467 ABDOMINAL DISTENSION 12 0.0001
468 URINE OUTPUT DECREASED 1 0.0001
469 NAIL DISORDER 1 0.0001
470 FEELING HOT 7 0.0001
471 HYPOXIA 4 0.0001
472 LUNG INFILTRATION 1 0.0001
473 CARDIOTOXICITY 1 0.0001
474 ISCHAEMIC STROKE 2 0.0001
475 GASTROINTESTINAL INFECTION 1 0.0001
476 JAUNDICE 3 0.0001
477 ANAL INCONTINENCE 1 0.0001
478 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
479 UROSEPSIS 1 0.0001
480 IRON DEFICIENCY ANAEMIA 1 0.0001
481 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
482 DYSGEUSIA 8 0.0001
483 ERYTHEMA MULTIFORME 1 0.0001
484 BACTERIAL INFECTION 2 0.0001
485 COGNITIVE DISORDER 5 0.0001
486 ASTHENIA 40 0.0001
487 ARTERIOSCLEROSIS 1 0.0001
488 BLOOD SODIUM DECREASED 2 0.0001
489 FRACTURE 2 0.0001
490 PROTEINURIA 2 0.0001
491 RED BLOOD CELL COUNT DECREASED 3 0.0001
492 PRODUCTIVE COUGH 5 0.0001
493 GENERAL PHYSICAL HEALTH DETERIORATION 12 0.0001
494 HAEMORRHOIDS 2 0.0001
495 PHARYNGEAL SWELLING 1 0.0001
496 BODY TEMPERATURE DECREASED 1 0.0001
497 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
498 LEUKOPENIA 5 0.0001
499 APHASIA 3 0.0001
500 CELLULITIS 5 0.0001
501 SUBARACHNOID HAEMORRHAGE 1 0.0001
502 FEMUR FRACTURE 3 0.0001
503 PERITONITIS 2 0.0001
504 EYE DISCHARGE 1 0.0001
505 PULMONARY HYPERTENSION 2 0.0001
506 DERMATITIS 2 0.0001
507 JOINT DISLOCATION 1 0.0001
508 HYPOTHYROIDISM 3 0.0001
509 MOVEMENT DISORDER 3 0.0001
510 DECREASED ACTIVITY 1 0.0001
511 SKIN LACERATION 1 0.0001
512 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
513 OESOPHAGITIS 1 0.0001
514 DYSPEPSIA 9 0.0001
515 GASTROINTESTINAL PAIN 1 0.0001
516 RENAL FAILURE 12 0.0001
517 BLOOD PRESSURE DECREASED 6 0.0001
518 LIVER DISORDER 4 0.0001
519 MITRAL VALVE INCOMPETENCE 1 0.0001
520 CHOLECYSTECTOMY 1 0.0001
521 THROMBOSIS 7 0.0001
522 GASTRIC HAEMORRHAGE 1 0.0001
523 METASTASES TO LUNG 1 0.0001
524 HYPOTENSION 17 0.0001
525 HYPOGLYCAEMIA 4 0.0001
526 CYTOPENIA 1 0.0001
527 HYPERCALCAEMIA 1 0.0001
528 HYPERSENSITIVITY 15 0.0001
529 AGEUSIA 2 0.0001
530 DYSARTHRIA 3 0.0001
531 TACHYCARDIA 7 0.0001
532 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
533 HEPATITIS 2 0.0001
534 GASTROINTESTINAL DISORDER 7 0.0001
535 HAEMOGLOBIN DECREASED 8 0.0001
536 UNRESPONSIVE TO STIMULI 2 0.0001
537 INFECTION 11 0.0001
538 PULMONARY CONGESTION 1 0.0001
539 SARS-COV-2 TEST POSITIVE 1 0.0001
540 UVEITIS 1 0.0001
541 TACHYPNOEA 1 0.0001
542 PNEUMONITIS 2 0.0001
543 HEPATIC ENZYME INCREASED 5 0.0001
544 ACUTE HEPATIC FAILURE 1 0.0001
545 RESPIRATORY DISTRESS 2 0.0001
546 DIVERTICULITIS 2 0.0001
547 MENTAL STATUS CHANGES 2 0.0001
548 ATRIAL FIBRILLATION 7 0.0001
549 SEPSIS 8 0.0001
550 ABDOMINAL DISCOMFORT 12 0.0001
551 DEVICE OCCLUSION 1 0.0001
552 LYMPHOPENIA 1 0.0001
553 SINUS TACHYCARDIA 1 0.0001
554 MUSCULAR WEAKNESS 8 0.0001
555 GASTROENTERITIS 1 0.0001
556 URINARY INCONTINENCE 2 0.0001
557 THROAT IRRITATION 3 0.0001
558 THERAPY NON-RESPONDER 3 0.0001
559 BLOOD POTASSIUM DECREASED 2 0.0001
560 DIABETES MELLITUS 5 0.0001
561 PNEUMONIA 21 0.0001
562 CONSTIPATION 14 0.0001
563 THERAPY PARTIAL RESPONDER 1 0.0001
564 BRAIN FOG 1 0.0001
565 DRUG-INDUCED LIVER INJURY 2 0.0001
566 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
567 COVID-19 11 0.0001
568 SENSORY DISTURBANCE 1 0.0001
569 STAPHYLOCOCCAL INFECTION 2 0.0001
570 HEART RATE INCREASED 6 0.0001
571 FATIGUE 47 0.0001
572 FUNGAL INFECTION 2 0.0001
573 BLOOD UREA INCREASED 1 0.0001
574 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
575 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
576 CANDIDA INFECTION 1 0.0001
577 HAEMATURIA 2 0.0001
578 DYSPNOEA 33 0.0001
579 COUGH 16 0.0001
580 BRADYCARDIA 3 0.0001
581 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
582 DRUG ERUPTION 1 0.0001
583 THIRST 1 0.0001
584 OFF LABEL USE 49 0.0001
585 GOUT 1 0.0001
586 DEATH 48 0.0001
587 LEUKOCYTOSIS 1 0.0001
588 OSTEOMYELITIS 1 0.0001
589 SOMNOLENCE 11 0.0001
590 HYPERHIDROSIS 7 0.0001
591 BLOOD GLUCOSE ABNORMAL 1 0.0001
592 CHEST PAIN 10 0.0001
593 HEPATIC STEATOSIS 1 0.0001
594 THROMBOCYTOPENIA 6 0.0001
595 CEREBROVASCULAR ACCIDENT 9 0.0001
596 HOT FLUSH 4 0.0001
597 SLEEP APNOEA SYNDROME 1 0.0001
598 HERPES ZOSTER 3 0.0001
599 POST PROCEDURAL COMPLICATION 1 0.0001
600 LOWER LIMB FRACTURE 1 0.0001
601 ACUTE RESPIRATORY FAILURE 1 0.0001
602 ERUCTATION 1 0.0001
603 BACK PAIN 12 0.0001
604 DYSPHONIA 3 0.0001
605 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
606 HAEMATOCRIT DECREASED 1 0.0001
607 SPINAL FRACTURE 1 0.0000
608 DISCOMFORT 3 0.0000
609 BODY TEMPERATURE INCREASED 1 0.0000
610 PRODUCT PREPARATION ERROR 1 0.0000
611 LUNG NEOPLASM MALIGNANT 2 0.0000
612 RASH 21 0.0000
613 DIZZINESS 24 0.0000
614 CARDIO-RESPIRATORY ARREST 2 0.0000
615 MOUTH ULCERATION 1 0.0000
616 RECTAL HAEMORRHAGE 2 0.0000
617 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
618 BLOOD CREATININE INCREASED 3 0.0000
619 PRODUCT DISPENSING ERROR 1 0.0000
620 PRODUCT PRESCRIBING ISSUE 1 0.0000
621 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
622 FALL 15 0.0000
623 STEVENS-JOHNSON SYNDROME 1 0.0000
624 TOOTH DISORDER 1 0.0000
625 HEPATOTOXICITY 1 0.0000
626 PULMONARY OEDEMA 2 0.0000
627 ORAL PAIN 1 0.0000
628 RASH PAPULAR 1 0.0000
629 SNEEZING 1 0.0000
630 PANCREATITIS ACUTE 1 0.0000
631 MUSCLE TWITCHING 1 0.0000
632 PERICARDIAL EFFUSION 1 0.0000
633 OROPHARYNGEAL PAIN 4 0.0000
634 RENAL DISORDER 2 0.0000
635 HYPERTENSION 9 0.0000
636 MENTAL IMPAIRMENT 1 0.0000
637 RESPIRATORY FAILURE 3 0.0000
638 URINARY TRACT INFECTION 7 0.0000
639 LIVER INJURY 1 0.0000
640 EXTRAPYRAMIDAL DISORDER 1 0.0000
641 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
642 FLUID RETENTION 2 0.0000
643 DEAFNESS 1 0.0000
644 FREQUENT BOWEL MOVEMENTS 1 0.0000
645 PALLOR 1 0.0000
646 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
647 ANAPHYLACTIC REACTION 2 0.0000
648 CONDITION AGGRAVATED 11 0.0000
649 FLATULENCE 2 0.0000
650 LETHARGY 2 0.0000
651 LIVER FUNCTION TEST ABNORMAL 1 0.0000
652 DYSSTASIA 1 0.0000
653 PALPITATIONS 4 0.0000
654 CATARACT 2 0.0000
655 HEPATIC FAILURE 1 0.0000
656 THERAPEUTIC RESPONSE DECREASED 2 0.0000
657 VERTIGO 2 0.0000
658 SWOLLEN TONGUE 1 0.0000
659 BLOOD GLUCOSE INCREASED 6 0.0000
660 METABOLIC ACIDOSIS 1 0.0000
661 HIP FRACTURE 1 0.0000
662 DRUG INTOLERANCE 3 0.0000
663 RHINORRHOEA 2 0.0000
664 SYNCOPE 3 0.0000
665 SKIN DISORDER 1 0.0000
666 NEOPLASM MALIGNANT 2 0.0000
667 GAIT INABILITY 1 0.0000
668 TYPE 2 DIABETES MELLITUS 1 0.0000
669 TOXICITY TO VARIOUS AGENTS 5 0.0000
670 INJURY 2 0.0000
671 LYMPHADENOPATHY 1 0.0000
672 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
673 ACCIDENTAL OVERDOSE 1 0.0000
674 RESTLESSNESS 1 0.0000
675 DYSURIA 1 0.0000
676 EPISTAXIS 2 0.0000
677 DYSPNOEA EXERTIONAL 1 0.0000
678 SEIZURE 3 0.0000
679 ABNORMAL BEHAVIOUR 1 0.0000
680 DRY MOUTH 2 0.0000
681 ERYTHEMA 5 0.0000
682 INFLUENZA LIKE ILLNESS 2 0.0000
683 RHABDOMYOLYSIS 1 0.0000
684 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
685 MENTAL DISORDER 1 0.0000
686 PRODUCT STORAGE ERROR 2 0.0000
687 WEIGHT INCREASED 5 0.0000
688 ARRHYTHMIA 1 0.0000
689 DISEASE RECURRENCE 1 0.0000
690 GAIT DISTURBANCE 4 0.0000
691 FEELING ABNORMAL 5 0.0000
692 BLOOD GLUCOSE DECREASED 1 0.0000
693 LUNG DISORDER 1 0.0000
694 ALOPECIA 4 0.0000
695 AGGRESSION 1 0.0000
696 PERIPHERAL SWELLING 3 0.0000
697 RASH PRURITIC 1 0.0000
698 TREMOR 3 0.0000
699 INFLUENZA 2 0.0000
700 BLISTER 1 0.0000
701 MYALGIA 3 0.0000
702 SURGERY 1 0.0000
703 NASAL CONGESTION 1 0.0000
704 BLADDER CANCER 1 0.0000
705 WHEEZING 1 0.0000
706 MUSCLE SPASMS 3 0.0000
707 HEADACHE 10 0.0000
708 LOSS OF CONSCIOUSNESS 2 0.0000
709 AMNESIA 1 0.0000
710 ARTHRALGIA 6 0.0000
711 BURNING SENSATION 1 0.0000
712 SLEEP DISORDER 1 0.0000
713 MOBILITY DECREASED 1 0.0000
714 OVERDOSE 3 0.0000
715 AGITATION 1 0.0000
716 ARTHRITIS 1 0.0000
717 PARAESTHESIA 2 0.0000
718 DRUG INTERACTION 2 0.0000
719 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
720 CONFUSIONAL STATE 2 0.0000
721 CARDIAC ARREST 1 0.0000
722 COMPLETED SUICIDE 1 0.0000
723 URTICARIA 2 0.0000
724 MYOCARDIAL INFARCTION 2 0.0000
725 INSOMNIA 3 0.0000
726 CARDIAC DISORDER 1 0.0000
727 SWELLING 1 0.0000
728 CONTUSION 1 0.0000
729 PAIN IN EXTREMITY 3 0.0000
730 SINUSITIS 1 0.0000
731 ILLNESS 1 0.0000
732 INCORRECT DOSE ADMINISTERED 2 0.0000
733 JOINT SWELLING 1 0.0000
734 PAIN 5 0.0000
735 VISUAL IMPAIRMENT 1 0.0000
736 PRURITUS 3 0.0000
737 DRY SKIN 1 0.0000
738 VISION BLURRED 1 0.0000
739 MEMORY IMPAIRMENT 1 0.0000
740 DRUG INEFFECTIVE 9 0.0000
741 DEPRESSION 1 0.0000
742 ANXIETY 1 0.0000
743 INJECTION SITE PAIN 1 0.0000